EGFR and non-small cell lung carcinoma: In 2023, Nie et al. [28] also demonstrated how the interaction between long noncoding RNA SNHG1 (whose expression is increased in NSCLC cells by HPV16 E6) and EGFR can activate a downstream pathway that promotes tumor angiogenesis and VEGF (vascular endothelial growth factor) expression.